Covaxin output is all set to be ramped up to 5.5 crore doses in October from to 3.5 crore doses in September, Bharat Biotech’s chairman & managing director Dr Krishna Ella said on Tuesday. Pointing out that production at the Biovet facility in Bengaluru is catching up very fast, Ella said that output from Bengaluru will increase from October as the company had got the licence only one week back for one facility.from India News | Latest News Headlines & Live Updates from India - Times of India https://ift.tt/3tW3OpJ
